Mediquity Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 151.23%
(FY 2023)
- Profit 151.11%
(FY 2023)
- Ebitda 208.74%
(FY 2023)
- Net Worth 50.37%
(FY 2023)
- Total Assets 138.71%
(FY 2023)
About Mediquity Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saurabh Garg, Jitendra Tiwari, and Aparna Shrivastava serve as directors at the Company.
- CIN/LLPIN
U72900UP2021PTC147589
- Company No.
147589
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mediquity Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurabh Garg  | Director | 22-Jun-2021 | Current |
| Jitendra Tiwari | Director | 22-Jun-2021 | Current |
| Aparna Shrivastava | Director | 22-Jun-2021 | Current |
Financial Performance of Mediquity Technologies.
Mediquity Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 151.23% increase. The company also saw a substantial improvement in profitability, with a 151.11% increase in profit. The company's net worth Soared by an impressive increase of 50.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediquity Technologies?
Unlock access to Mediquity Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Syndicate Diagnostics Private LimitedActive 12 years 8 monthsSaurabh Garg and Jitendra Tiwari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediquity Technologies?
Mediquity Technologies has a workforce of 51 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediquity Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediquity Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
